Articles
The ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 1)

The ‘supply chain’ patient is sick: is there a cure for the ...

In the first of two parts, Hedley Rees looks at the problems with the pharmaceutical supply chain and questions whether they can be resolved. The Pharmaceutical supply chain has never been in such turmoil and under such attack from governments and regulators globally. The evidence is...

Articles
HIV/AIDS statistics in South Africa: and the possible implications for the tx and dx industries (part 2)

HIV/AIDS statistics in South Africa: and the possible implic...

Chris Jennings continues his article highlighting ways in which he believes HIV / AIDS incidence have been overestimated. As described in Part I of this article, few people realize that the familiar HIV/AIDS global statistics are actually estimates. For example...

Articles
The ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 2)

The ‘supply chain’ patient is sick: is there a cure for the ...

In his concluding article Hedley Rees looks at the cure for the ‘sick’ pharmaceutical supply chain. Well, is there a treatment option? Yes, I would say there is, and the regulators certainly think so too, having been pressing the industry for nearly...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. FDA nominee Overton dodges questions on Trump influence
  2. Australia starts probe into AI infiltration of Medicare
  3. Lilly forges $3.35bn alliance with China's InnoCare
  4. Telix to buy radiopharma rival ITM for $1.65bn upfront
  5. Advocacy group pokes holes in Trump's MFN pricing claims

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more